Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Stacey Martiniano, MD

Pediatric Pulmonology

Board Certified

Stacey Martiniano

Clinical Interest for Patients

Dr. Martiniano is an Associate Professor of Pediatrics at the University of Colorado and Children’s Hospital Colorado. She is a pediatric pulmonologist who focuses on lung infections, specifically, nontuberculous mycobacterial infections in children with cystic fibrosis.

Credentials

Doctor of Medicine

Specialty

Pediatrics, Pediatric Pulmonology

Scheduling Phone Number

720-777-1234

Gender

Female

Languages

English

Hospital Affiliation

University of Colorado Hospital, Children's Hospital Colorado

Provider Information

  • Pediatrics (2009)
  • Pediatric Pulmonology (2012)
  • Lungs and Breathing

    Cystic Fibrosis , Lung Disease , Pulmonary Disorders

Professor, Pediatrics-Pulmonary Medicine

American College of Chest Physicians (ACCP), Member American Thoracic Society (ATS), Member

Grants

T32 Training Grant for Fellowship Training (2010)

Cystic Fibrosis (CF) Nontuberculous Mycobacteria Diagnosis and Treatment Pilot Program (2013)

Harry Shwachman Clinical Investogator Award (2014)

Newborn Screening for Cystic Fibrosis (2014)

Improving Treatment of Nontuberculous Mycobacterial Infection in CF (2014)

Colorado CF Research Development Program (2015)

Research Interests for Patients

As a national clinical expert and lead researcher, Dr. Martiniano serves as national principal investigator of two multicenter studies in NTM: The Prospective Evaluation of NTM Disease in Cystic Fibrosis (PREDICT Study) and The Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (PATIENCE Study). Both are funded by the Cystic Fibrosis Foundation. She is also the co-investigator and director of the Clinical Research Core for the Cystic Fibrosis Foundation Colorado’s CF NTM Research Development Program. Her clinical and translational research has already confirmed the rate of the infection and established the feasibility of new clinical tools such as diagnostic algorithms. Over time, Dr. Martiniano seeks not only to improve outcomes for patients with NTM, but also to help clinicians and the broader cystic fibrosis community care for kids with cystic fibrosis and NTM.

Education and Training

Medical Schools

MD, University of Rochester School of Medicine and Dentistry (2006)


Undergraduate Schools

BS, University of Rochester (NY) (2001)


Graduate Schools

MSCS, University of Colorado Health Sciences Center (2016)


Residency Program

McGaw Medical Center of Northwestern University/Children's Memorial Hospital Program (2009)


Fellowships

University of Colorado (Children's Hospital Colorado) Program (2012)

University of Colorado (Children's Hospital Colorado) Program (2013)

Information for referring providers

Referral Contact Phone

720-777-1234

720-777-1234

Referring Patients Link

Information for Referring and Transferring Patients

Research Interest for Referring Providers

Dr. Martiniano is an Associate Professor of Pediatrics at the University of Colorado and Children’s Hospital Colorado. She is a pediatric pulmonologist who focuses on lung infections, specifically, nontuberculous mycobacterial infections in children with cystic fibrosis. As a national clinical expert and lead researcher, Dr. Martiniano serves as national principal investigator of two multicenter studies in NTM: The Prospective Evaluation of NTM Disease in Cystic Fibrosis (PREDICT Study) and The Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (PATIENCE Study). Both are funded by the Cystic Fibrosis Foundation. She is also the co-investigator and director of the Clinical Research Core for the Cystic Fibrosis Foundation Colorado’s CF NTM Research Development Program. Her clinical and translational research has already confirmed the rate of the infection and established the feasibility of new clinical tools such as diagnostic algorithms. Over time, Dr. Martiniano seeks not only to improve outcomes for patients with NTM, but also to help clinicians and the broader cystic fibrosis community care for kids with cystic fibrosis and NTM.